Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges
Author:
Funder
National Natural Science Foundation of China
Henan Provincial Science and Technology Research Project
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s40262-024-01391-2.pdf
Reference211 articles.
1. Sudsakorn S, Bahadduri P, Fretland J, Lu C. 2020 FDA drug-drug interaction guidance: a comparison analysis and action plan by pharmaceutical industrial scientists. Curr Drug Metab. 2020;21(6):403–26.
2. Krichbaum M, Miransky N, Perez A. Trends in pain medication use in patients with type 2 diabetes: NHANES 2005–2018. J Pain Palliat Care Pharmacother. 2023;37(3):223–33.
3. Hau RK, Wright SH, Cherrington NJ. Addressing the clinical importance of equilibrative nucleoside transporters in drug discovery and development. Clin Pharmacol Ther. 2023;114(4):780–94.
4. Mease J, Ramamoorthy A, Yang X, Madabushi R, Pfuma FE, Zineh I. Statin drug-drug interactions: pharmacokinetic basis of FDA labeling recommendations and comparison across common tertiary clinical resources. J Clin Pharmacol. 2024;64(4):704–12.
5. Su YY, Chiang NJ, Chang JS, Wang YW, Shen BN, Li YJ, et al. The association between UGT1a1 polymorphisms and treatment toxicities of liposomal irinotecan. Esmo Open. 2023;8(1): 100746.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3